Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
78.22
+0.97 (1.26%)
Dec 26, 2024, 4:00 PM EST - Market closed
PRAX Revenue
Praxis Precision Medicines had revenue of $302.00K in the quarter ending September 30, 2024, a decrease of -35.47%. This brings the company's revenue in the last twelve months to $1.61M, down -16.93% year-over-year. In the year 2023, Praxis Precision Medicines had annual revenue of $2.45M.
Revenue (ttm)
$1.61M
Revenue Growth
-16.93%
P/S Ratio
n/a
Revenue / Employee
$19,573
Employees
82
Market Cap
1.46B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AtriCure | 447.57M |
InMode | 423.75M |
Phreesia | 405.14M |
Kiniksa Pharmaceuticals International, | 384.10M |
Immunocore Holdings | 296.31M |
Arcus Biosciences | 263.00M |
Travere Therapeutics | 203.45M |
Schrödinger | 193.35M |
PRAX News
- 8 days ago - Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome - GlobeNewsWire
- 21 days ago - GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners - Business Wire
- 23 days ago - Praxis Precision Medicines to Present at Upcoming December Investor Conferences - GlobeNewsWire
- 7 weeks ago - Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences - GlobeNewsWire
- 7 weeks ago - Praxis Precision Medicines, Inc. (PRAX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - GlobeNewsWire
- 4 months ago - Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations - GlobeNewsWire